Zobrazeno 1 - 10
of 705
pro vyhledávání: '"Xaliproden"'
Publikováno v:
International Journal of Nanomedicine, Vol Volume 19, Pp 10387-10400 (2024)
Yajie Wang,1,* Bo Yuan,2,* Wei Liu,3,* Jianlin Cui,2 Xueyan Zhou,2 Liyun Yuan,2 Zihao Deng,4 Yuhao Li,5,6 Xiaoyong Yuan1,2 1Tianjin Eye Hospital, Tianjin Key Laboratory of Ophthalmology and Visual Science, Tianjin Eye Institute, Tianjin,
Externí odkaz:
https://doaj.org/article/348a8dc8c401471dad69821883885653
Publikováno v:
In European Journal of Pharmacology 5 December 2013 721(1-3):231-236
Publikováno v:
Journal of Pharmacological Sciences, Vol 131, Iss 4, Pp 284-287 (2016)
Oxaliplatin causes peripheral neuropathy as a major dose-limiting side effect, and the control of this neuropathy is difficult. This study was designed to investigate whether prophylactic repetitive administration of 5-HT1A receptor agonists inhibits
Externí odkaz:
https://doaj.org/article/b04d92f98c254652969c07d3f1d8acff
Autor:
Limited, Adis International
Publikováno v:
Drugs in R&D. 2003, Vol. 4 Issue 6, p386-388. 3p. 2 Charts.
Autor:
Lacomblez, Lucette1 lucette.lacomblez@psl.ap-hop-paris.fr, Bensimon, Gilbert1, Douillet, Patrice2, Doppler, Valérie1, Salachas, Francois1, Meininger, Vincent1
Publikováno v:
Amyotrophic Lateral Sclerosis & Other Motor Neuron Disorders. Jun2004, Vol. 5 Issue 2, p99-106. 8p.
Efficacy and safety of xaliproden in amyotrophic lateral sclerosis: results of two phase III trials.
Autor:
Meininger, Vincent1 vincent.meininger@psl.ap-hop-paris.fr, Bensimon, Gilbert1, Bradley, Walter G.2, Brooks, Benjamin R.3, Douillet, Patrice4, Eisen, Andrew A.5, Lacomblez, Lucette1, Leigh, P. Nigel6, Robberecht, Wim7
Publikováno v:
Amyotrophic Lateral Sclerosis & Other Motor Neuron Disorders. Jun2004, Vol. 5 Issue 2, p107-117. 11p.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Martel, J-C1, Assié, M-B1, Bardin, L1, Depoortère, R1, Cussac, D2, Newman-Tancredi, A1, Assié, M-B (AUTHOR), Depoortère, R (AUTHOR)
Publikováno v:
British Journal of Pharmacology. Sep2009, Vol. 158 Issue 1, p232-242. 11p.
Publikováno v:
European Journal of Pharmacology. 721:231-236
In the present study we investigated whether xaliproden, a selective 5-HT1A receptor agonist, could relieve allodynia induced by three types of chemotherapeutic agents (paclitaxel, vincristine, and oxaliplatin) in mice. A single intraperitoneal injec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3ef95d28a4da9074f00a27e007ba9421
https://doi.org/10.1016/j.ejphar.2013.09.030
https://doi.org/10.1016/j.ejphar.2013.09.030
Autor:
Francis Taulelle, Bertrand Castro, Ravi Kumar Chandrappa, Michel Bonin, Harold Malandrini, Mohamed El Hajji, Charlotte Martineau, Frank Engelke, Philippe Ochsenbein, Gerhard Althoff
Publikováno v:
Crystal Growth & Design. 13:4678-4687
Three polymorphic phases of xaliproden are evidenced through thermal analysis: Form II has an orthorhombic symmetry, while Forms I and III have monoclinic unit cells. Structural characterizations of xaliproden are carried out by means of single-cryst
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::72e78f674606eed491df14cab01b60df
https://doi.org/10.1021/cg400441r
https://doi.org/10.1021/cg400441r